Swiss National Bank’s XBiotech XBIT Stock Holding History

Swiss National Bank’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46,800	Closed	-$404K	–	2797
2022 Q1	$404K	Buy	46,800 +3,800	+9%	+$38.1K	﹤0.01%	2628
2021 Q4	$479K	Hold	43,000	–	–	﹤0.01%	2673
2021 Q3	$557K	Buy	43,000 +1,100	+3%	+$17.5K	﹤0.01%	2570
2021 Q2	$694K	Buy	41,900 +8,500	+25%	+$144K	﹤0.01%	2584
2021 Q1	$573K	Buy	33,400 +1,200	+4%	+$22.4K	﹤0.01%	2447
2020 Q4	$504K	Hold	32,200	–	–	﹤0.01%	2461
2020 Q3	$615K	Hold	32,200	–	–	﹤0.01%	2310
2020 Q2	$441K	Buy	+32,200	New	+$453K	﹤0.01%	2402
2017 Q4	–	Sell	-31,500	Closed	-$138K	–	2534
2017 Q3	$138K	Hold	31,500	–	–	﹤0.01%	2521
2017 Q2	$148K	Hold	31,500	–	–	﹤0.01%	2556
2017 Q1	$519K	Hold	31,500	–	–	﹤0.01%	2365
2016 Q4	$319K	Hold	31,500	–	–	﹤0.01%	2507
2016 Q3	$424K	Sell	31,500 -2,800	-8%	-$41.1K	﹤0.01%	2403
2016 Q2	$718K	Buy	+34,300	New	+$495K	﹤0.01%	2157

Other funds holding XBIT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Swiss National Bank's XBIT Position: Q2 2022 in Review

Swiss National Bank sold out of XBiotech (XBIT) in Q2 2022, closing a stake of 46,800 shares — an estimated $404K sold.

Swiss National Bank first reported a position in XBIT in Q2 2016 and held it in 14 quarters. The position peaked at $718K in Q2 2016. 56 funds tracked by Wall St. Rank hold XBIT as of Q2 2022.

Swiss National Bank reported no remaining XBiotech position as of Q2 2022 after selling out during the quarter.
Swiss National Bank sold 46,800 XBiotech shares in Q2 2022, an estimated $404K.
Swiss National Bank first reported a position in XBiotech in Q2 2016 and held it in 14 quarters.
Swiss National Bank's XBiotech position peaked at $718K in Q2 2016.
56 funds tracked by Wall St. Rank held XBiotech as of Q2 2022.

Based on Swiss National Bank's 13F filing for Q2 2022, filed 9 Aug 2022.